Itron (NASDAQ:ITRI) SVP John Marcolini Sells 6,948 Shares

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 6,948 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total transaction of $691,603.92. Following the completion of the sale, the senior vice president owned 26,912 shares of the company’s stock, valued at approximately $2,678,820.48. The trade was a 20.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Itron Stock Down 1.8%

Shares of Itron stock traded down $1.84 on Monday, hitting $97.70. 522,620 shares of the company traded hands, compared to its average volume of 759,610. Itron, Inc. has a 12-month low of $88.57 and a 12-month high of $142.00. The company has a quick ratio of 1.56, a current ratio of 1.80 and a debt-to-equity ratio of 0.45. The company has a market cap of $4.39 billion, a PE ratio of 15.01, a PEG ratio of 0.86 and a beta of 1.48. The company has a 50-day moving average price of $97.72 and a 200 day moving average price of $109.93.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.19 by $0.27. Itron had a return on equity of 20.04% and a net margin of 12.72%.The firm had revenue of $571.66 million during the quarter, compared to analysts’ expectations of $561.31 million. During the same quarter last year, the firm earned $1.35 earnings per share. The business’s revenue for the quarter was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Sell-side analysts predict that Itron, Inc. will post 5.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ITRI. Robert W. Baird set a $128.00 price objective on Itron and gave the company an “outperform” rating in a report on Wednesday, February 18th. Argus reissued a “hold” rating on shares of Itron in a research report on Tuesday, November 4th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research note on Monday, January 5th. Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Finally, Oppenheimer upped their price target on shares of Itron from $125.00 to $133.00 and gave the company an “outperform” rating in a report on Wednesday. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $137.90.

Hedge Funds Weigh In On Itron

A number of institutional investors and hedge funds have recently bought and sold shares of ITRI. EverSource Wealth Advisors LLC grew its holdings in Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after acquiring an additional 81 shares during the period. Amalgamated Bank grew its holdings in Itron by 0.7% during the third quarter. Amalgamated Bank now owns 13,060 shares of the scientific and technical instruments company’s stock worth $1,627,000 after buying an additional 86 shares in the last quarter. PFG Investments LLC lifted its position in shares of Itron by 4.8% during the third quarter. PFG Investments LLC now owns 2,059 shares of the scientific and technical instruments company’s stock valued at $256,000 after purchasing an additional 94 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after buying an additional 101 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC boosted its stake in shares of Itron by 3.5% in the 2nd quarter. Elevation Point Wealth Partners LLC now owns 3,398 shares of the scientific and technical instruments company’s stock worth $447,000 after buying an additional 115 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.